1.79

1.79 (-0.03%)

As of Jan 14, 2022

Alzamend Neuro, Inc. [ALZN]

Source: 

Company Overview

Alzamend Neuro, Inc is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease, bipolar disorder, major depressive disorder and post-traumatic stress disorder.

CountryUS
Headquartersatlantageorgia
Phone Number(844) 722-6333
Industrypharmaceutical preparations
CEOStephan Jackman
Websitewww.alzamend.com

Recent Stories